Latest News about TAK
Recent news which mentions TAK
Why Is AC Immune (ACIU) Stock Up 45% Today?
May 13, 2024
From InvestorPlace
Japan's Takeda Pharma Outlines $900M Overhaul To Boost Growth, As 2023 Profit Fall Over 50%
May 09, 2024
From Benzinga
Tickers
TAK
From InvestorPlace
Neurocrine Biosciences Says Treatment Can Alleviate Several Symptoms Associated With Depressive Disorder
April 23, 2024
From Benzinga
The Hot List: 3 AI Stocks Worth Buying on Weakness
March 01, 2024
From InvestorPlace
From Benzinga
Good News For Sleep Disorder Patients - Takeda's Therapy Shows Promise In Mid-Stage Study
February 09, 2024
From Benzinga
Why Is Japanese Drugmaker Takeda Stock Trading Lower Today?
February 01, 2024
From Benzinga
Earnings Scheduled For February 1, 2024
February 01, 2024
From Benzinga
3 Stocks to Buy to Benefit From the Booming Sleep Industry
January 23, 2024
From InvestorPlace
Looking Into Takeda Pharmaceutical's Recent Short Interest
January 15, 2024
Tickers
TAK
From Benzinga
Expensive Drugs For Americans In 2024? Drugmakers Including Pfizer, Sanofi Mull Price Increase In January
December 29, 2023
From Benzinga
(TAK) - Analyzing Takeda Pharmaceutical's Short Interest
December 25, 2023
Tickers
TAK
From Benzinga
From Benzinga
(TAK) - Analyzing Takeda Pharmaceutical's Short Interest
December 07, 2023
Tickers
TAK
From Benzinga
Peering Into Takeda Pharmaceutical's Recent Short Interest
November 21, 2023
Tickers
TAK
From Benzinga
Why Is Neurocrine Biosciences Stock Trading Lower Today?
November 10, 2023
From Benzinga
Neurocrine Biosciences shares drop as trial failures may ‘stunt momentum,’ analysts say
November 10, 2023
From MarketWatch
Back To Back FDA Approval For Takeda Within Two Days, Secures Green Signal For Rare Blood Disorder Therapy
November 10, 2023
Tickers
TAK
From Benzinga
3 Promising Biotech Stocks Flying Under the Radar
November 08, 2023
From InvestorPlace
Looking Into Takeda Pharmaceutical's Recent Short Interest
November 03, 2023
Tickers
TAK
From Benzinga
Earnings Scheduled For October 26, 2023
October 26, 2023
From Benzinga
A Look Into Takeda Pharmaceutical Inc's Price Over Earnings
October 19, 2023
Tickers
TAK
From Benzinga
Takeda's Crohn's Disease Fistulas Candidates Fall Short In Mid-Stage Study, Settles Tax Dispute With Irish Revenue Commissioners
October 18, 2023
From Benzinga
Looking Into Takeda Pharmaceutical's Recent Short Interest
October 11, 2023
Tickers
TAK
From Benzinga
A Look Into Takeda Pharmaceutical Inc's Price Over Earnings
October 04, 2023
Tickers
TAK
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 02, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.